(Q37067679)

English

The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects

scientific article published on December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

Europe PubMed Central

The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

1 reference

based on heuristic

inferred from title

author name string

Sungho Maeng

1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Carlos A Zarate

2

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

language of work or name

0 references

publication date

1 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Current Psychiatry Reports

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

467-474

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Plasma and platelet excitatory amino acids in psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0063-1

21 January 2018

Role of the NMDA receptor NR2B subunit in the discriminative stimulus effects of ketamine

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0063-1

21 January 2018

Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0063-1

21 January 2018

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1007%2FS11920-007-0063-1

21 January 2018

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Timing is everything: does the robust upregulation of noradrenergically regulated plasticity genes underlie the rapid antidepressant effects of sleep deprivation?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1-aminocyclopropanecarboxylates exhibit antidepressant and anxiolytic actions in animal models

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous ketamine for pediatric sedation in the emergency department: safety profile with 156 cases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroplasticity and cellular resilience in mood disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional impairment in the remission phase of bipolar disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sleep deprivation in depression: what do we know, where do we go?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Searching for rational anti N-methyl-D-aspartate treatment for depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New evidence for the antidepressant activity of MK-801, a non-competitive antagonist of NMDA receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label trial of riluzole in patients with treatment-resistant major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ras and Rap control AMPA receptor trafficking during synaptic plasticity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic treatment with 1-aminocyclopropanecarboxylic acid desensitizes behavioral responses to compounds acting at the N-methyl-D-aspartate receptor complex

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

AMPA receptor trafficking and synaptic plasticity

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Memantine inhibits ethanol-induced NMDA receptor up-regulation in rat hippocampal neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased cerebrospinal fluid glutamine levels in depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of trapping block of N-methyl-d-aspartate receptor channels.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between plasma levels of glutamate, alanine and serine with severity of depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled study of memantine in the treatment of major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant effects of ketamine in depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic administration of NMDA glycine partial agonists induces tolerance in the Porsolt swim test

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[D-cycloserine is active in the adult mouse and inactive in the aged mouse, in the forced swim test]

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low cerebrospinal fluid glutamate and glycine in refractory affective disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Memantine in moderate-to-severe Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and D-cycloserine in an animal model of depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disability and its treatment in bipolar disorder patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum glutamate in depressed patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of the NMDA receptor subunit in the expression of the discriminative stimulus effect induced by ketamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Behavioral and neuroendocrine effects of the partial NMDA agonist D-cycloserine in healthy subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies implementing glutamate neurotransmission in mood disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/18221626

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11920-007-0063-1

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37067679&oldid=2199826135"